$0.576
+0.062 (+10.71%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
KTTA 相似圖表分析預測
Alphio's KTTA stock price prediction model matches the current Pasithea Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.57 (-1.04%). The 1-week path is $0.57 (-0.88%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Pasithea Therapeutics Corp 股票嗎?
Pasithea Therapeutics Corp (KTTA) is a good buy right now due to its recent price increase of 55.51% over the last 5 days and the positive momentum indicated by an RSI of 81.843, suggesting strong buying pressure. The company has also received FDA clearance for its PAS-004 candidate, which could significantly enhance its market position in treating NF1-associated tumors. However, it is important to note that the company has a negative net income of -5,273,852 USD in Q2 2026, which poses a risk to its financial stability.
KTTA 股價於 Friday 收在 $0.58,此前上漲 +10.71%
Pasithea Therapeutics Corp (KTTA) last closed at $0.5757, gaining +10.71%. These facts feed the 1-day and 1-week KTTA price prediction above.
預測驅動因素
Pasithea Therapeutics Corp(KTTA)的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似圖表形態
近期走勢與 KTTA 最接近的股票,依相似度排序。
KTTA 季節性分析
Historically the probability of a positive November return for KTTA is 0.00%. April offers the highest probability of a positive month at 7.81%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
KTTA 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Nov 2026 | $0.61 | $0.74 | $0.75 | +28.48% |
| Dec 2026 | $0.78 | $0.83 | $0.95 | +43.76% |
2026 年,Pasithea Therapeutics Corp(KTTA)預計區間為 $0.61 至 $0.95。
Pasithea Therapeutics Corp 2026 年月度預測
2026 年 Nov,Pasithea Therapeutics Corp 預計均價 $0.74,最低 $0.61,最高 $0.75。
2026 年 Dec,Pasithea Therapeutics Corp 預計均價 $0.83,最低 $0.78,最高 $0.95。
相關文章
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
本頁僅供研究參考,不構成投資建議。模型可能出錯。過往表現不代表未來結果。